According to Genenta Science's latest financial reports the company has $20.75 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $31.9 M | -24.34% |
2021-12-31 | $42.17 M | 121.71% |
2020-12-31 | $19.02 M | -15.69% |
2019-12-31 | $22.56 M |